Russian government to stimulate production of APIs

27 April 2021
russia_lake_stock_large

The Russian government plans to stimulate the production of active pharmaceutical ingredients (APIs) for the domestic sector, as part of a recent order by the country’s President, Vladimir Putin.

In fact, the plans for localization of ingredients production in Russia were first announced about 10 years ago, although, so far a little progress in this field has been achieved.

At present about 80% of domestic drugs are produced on the basis of raw materials that are supplied to Russia from China and India, while in recent years the volume of such supplies has significantly increased, and the growth is currently ongoing.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics